SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-211527
Filing Date
2024-09-03
Accepted
2024-09-03 07:00:57
Documents
6
Period of Report
2024-10-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d817523ddef14a.htm DEF 14A 338851
2 GRAPHIC g817523g01g01.jpg GRAPHIC 37695
3 GRAPHIC g817523g03l16.jpg GRAPHIC 26948
4 GRAPHIC g817523g05a44.jpg GRAPHIC 36380
5 GRAPHIC g817523g61e00.jpg GRAPHIC 217585
6 GRAPHIC g817523g62o01.jpg GRAPHIC 202479
  Complete submission text file 0001193125-24-211527.txt   1048410
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39114 | Film No.: 241271879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)